Anxiety, depression, and comorbid anxiety and depression had a prevalence of 4.7%, 1.4%, and 1.8% in older adults, with symptoms persisting over two years in 31%, 23%, and 35% of cases.
Cohort (n=20,036)
Anxiety and depression frequently coexist in older adults, and their combination is associated with a more chronic course of illness.
BACKGROUND: This study aimed to determine: (1) the prevalence of depression, anxiety, and depression associated with anxiety (DA); (2) the risk factor profile of depression, anxiety, and DA; (3) the course of depression, anxiety, and DA over 24 months. METHODS: Two-year longitudinal study of 20,036 adults aged 60+ years. We used the Patient Health Questionnaire and the Hospital Anxiety and Depression Scale anxiety subscale to establish the presence of depression and anxiety, and standard procedures to collect demographic, lifestyle, psychosocial, and clinical data. RESULTS: The prevalence of anxiety, depression, and DA was 4.7%, 1.4%, and 1.8%. About 57% of depression cases showed evidence of comorbid anxiety, while only 28% of those with clinically significant anxiety had concurrent depression. There was not only an overlap in the distribution of risk factors in these diagnostic groups but also differences. We found that 31%, 23%, and 35% of older adults with anxiety, depression, and DA showed persistence of symptoms after two years. Repeated anxiety was more common in women and repeated depression in men. Socioeconomic stressors were common in repeated DA. CONCLUSIONS: Clinically significant anxiety and depression are distinct conditions that frequently coexist in later life; when they appear together, older adults endure a more chronic course of illness.
Almeida et al. (Wed,) conducted a cohort in Anxiety and depression (n=20,036). Anxiety and/or depression vs. No anxiety or depression was evaluated on Prevalence and 24-month persistence of anxiety, depression, and comorbid anxiety and depression. Anxiety, depression, and comorbid anxiety and depression had a prevalence of 4.7%, 1.4%, and 1.8% in older adults, with symptoms persisting over two years in 31%, 23%, and 35% of cases.